Institutional Ownership
Harmony Biosciences Hldgs In
CUSIP 413197104COMHRMYQ1 2026
13D / 13G Filings
37
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
19.7%
Max % of class reported
Institutional Holders
300
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
37 filings · latest Feb 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2026 | Fmr LLC | 13G/A | 5.4% | 3.11M | SEC |
| 2 | Nov 14, 2025 | Valor IV Pharma Holdings, LLC | 13G/A | 11.0% | 1.83M | SEC |
| 3 | Nov 5, 2025 | Fmr LLC | 13G/A | 6.7% | 3.85M | SEC |
| 4 | Apr 29, 2025 | Blackrock, Inc. | 13G/A | 10.1% | 5.77M | SEC |
| 5 | Feb 12, 2025 | Valor IV Pharma Holdings, LLC | 13G/A | 11.7% | 6.65M | SEC |
| 6 | Feb 10, 2025 | Marshman Fund Trust II | 13G/A | 10.6% | 6.05M | SEC |
| 7 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 12.2% | 6.97M | SEC |
| 8 | Jan 30, 2025 | The Vanguard Group | 13G/A | 8.3% | 4.73M | SEC |
| 9 | Feb 13, 2024 | Valor IV Pharma Holdings, LLC | 13G/A | 19.2% | 11.22M | SEC |
| 10 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 6.3% | 3.67M | SEC |
27 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Harmony Biosciences Hldgs In.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 7.07M | $198.03M |
| 2 | Fmr LLC | 3.16M | $88.45M |
| 3 | American Century Companies Inc | 2.11M | $58.97M |
| 4 | Dimensional Fund Advisors LP | 2.08M | $58.16M |
| 5 | State Street Corp | 1.78M | $49.98M |
| 6 | Armistice Capital, LLC | 1.62M | $45.49M |
| 7 | Arrowstreet Capital, Limited Partnership | 1.38M | $38.71M |
| 8 | Geode Capital Management, LLC | 1.32M | $37.05M |
| 9 | Goldman Sachs Group Inc | 1.24M | $34.71M |
| 10 | Renaissance Technologies LLC | 1.08M | $30.18M |